TBio-6517
TBio-6517-ITu-001
Phase 1 mab terminated
Quick answer
TBio-6517 for Solid Tumor is a Phase 1 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Solid Tumor
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated